The resting metabolic rate of people with severe mental illness: a systematic review and meta-analysis

Br J Nutr. 2023 Dec 28;130(12):2025-2038. doi: 10.1017/S0007114523001162. Epub 2023 May 9.

Abstract

People with severe mental illness (SMI), including schizophrenia and related psychoses and bipolar disorder, are at greater risk for obesity compared with people without mental illness. An altered resting metabolic rate (RMR) may be a key driving factor; however, published studies have not been systematically reviewed. This systematic review and meta-analysis aimed to determine whether the RMR of people with SMI assessed by indirect calorimetry differs from (i) controls, (ii) predictive equations and (iii) after administration of antipsychotic medications. Five databases were searched from database inception to March 2022. Thirteen studies providing nineteen relevant datasets were included. Study quality was mixed (62 % considered low quality). In the primary analysis, RMR in people with SMI did not differ from matched controls (n 2, standardised mean difference (SMD) = 0·58, 95 % CI -1·01, 2·16, P = 0·48, I2 = 92 %). Most predictive equations overestimated RMR. The Mifflin-St. Jeor equation appeared to be most accurate (n 5, SMD = -0·29, 95 % CI -0·73, 0·14, P = 0·19, I2 = 85 %). There were no significant changes in RMR after antipsychotic administration (n 4, SMD = 0·17, 95 % CI -0·21, 0·55, P = 0·38, I2 = 0 %). There is little evidence to suggest there is a difference in RMR between people with SMI and people without when matched for age, sex, BMI and body mass, or that commencement of antipsychotic medication alters RMR.

Keywords: Basal metabolism; Bipolar and related disorders; Calorimetry indirect; Mental disorders; Schizophrenia spectrum and other psychotic disorders.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Antipsychotic Agents* / therapeutic use
  • Basal Metabolism
  • Body Mass Index
  • Calorimetry, Indirect
  • Humans
  • Mental Disorders*
  • Predictive Value of Tests

Substances

  • Antipsychotic Agents